Neurocrine Biosciences Inc. (NASDAQ: NBIX) announced it has entered into a definitive agreement to acquire Soleno Therapeutics Inc. (NASDAQ: SLNO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE